Updates
May 8, 2015

Mark Up Scheduled in House Subcommittee

Recent hearings by Senate and House committees and a scheduled markup underscore Congress’ continued commitment to eliminating barriers that are slowing the development of effective drugs, devices, and biologics so that patients can access these safe and effective therapies sooner. Polsinelli has learned that the House of Representative’s Energy & Commerce Health subcommittee will vote on its reform legislation on May 14.

In an effort to expedite the process of bringing new therapies to patients, the Senate’s Health, Education Labor & Pensions committee and the Energy & Commerce Health subcommittee held hearings last week on improving the process for medical research and discovery at the National Institutes of Health (NIH) and the regulatory approval process within the Food and Drug Administration (FDA).

To view the full alert, click here.